Thursday, July 9, 2026

pharma · Advanced Solid Tumor · RNAZ

Transcode Therapeutics

Transcode Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Princeton, USA HQ
93 Employees
Public company Type
RNAZ · NYSE Ticker
Company details
Status
Public
HQ
Princeton, USA
Employees
93
Programs
2
Drugs
0
Patents
0
Intelligence · Clinical Programs

Transcode Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Transcode Therapeutics.

Transcode Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TTX-MC138

    Transcode Therapeutics

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Transcode Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.